Appeals Court Mulls Case Challenging FDA’s Emergency Authorization of COVID Vaccines for Kids

Plaintiffs argue US regulators are abusing their powers with the emergency authorization of COVID-19 vaccines for young children.

The U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu /The Epoch Times

The U.S. Food and Drug Administration (FDA) abused and is continuing to abuse its power by granting emergency authorization for COVID-19 vaccines for children and keeping the emergency clearance in place even after the COVID emergency ended, a federal court heard on Jan. 10.

The FDA has authorized the Moderna and Pfizer COVID-19 vaccines for children as young as 6 months of age despite insufficient evidence, mislabeling the gene therapy products as vaccines, and making false statements about their safety and efficacy, plaintiffs in the case say.